Matches in Wikidata for { <http://www.wikidata.org/entity/Q92704183> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q92704183 description "artículu científicu espublizáu n'abril de 2019" @default.
- Q92704183 description "bài báo khoa học" @default.
- Q92704183 description "im April 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92704183 description "scientific article published on 01 April 2019" @default.
- Q92704183 description "wetenschappelijk artikel" @default.
- Q92704183 description "наукова стаття, опублікована 1 квітня 2019" @default.
- Q92704183 name "Effective oral hypomethylating drugs in intermediate-risk or high-risk myelodysplasia: a breakthrough?" @default.
- Q92704183 name "Effective oral hypomethylating drugs in intermediate-risk or high-risk myelodysplasia: a breakthrough?" @default.
- Q92704183 type Item @default.
- Q92704183 label "Effective oral hypomethylating drugs in intermediate-risk or high-risk myelodysplasia: a breakthrough?" @default.
- Q92704183 label "Effective oral hypomethylating drugs in intermediate-risk or high-risk myelodysplasia: a breakthrough?" @default.
- Q92704183 prefLabel "Effective oral hypomethylating drugs in intermediate-risk or high-risk myelodysplasia: a breakthrough?" @default.
- Q92704183 prefLabel "Effective oral hypomethylating drugs in intermediate-risk or high-risk myelodysplasia: a breakthrough?" @default.
- Q92704183 P1433 Q92704183-CB539C84-A907-4063-ADC9-3FD18E862280 @default.
- Q92704183 P1476 Q92704183-A9E644EC-232B-4EFE-84F5-53A304B28436 @default.
- Q92704183 P2093 Q92704183-FEFB213E-57EA-45C1-8AC7-96B729008542 @default.
- Q92704183 P2860 Q92704183-0E43D2AE-B15E-404A-8962-B5415CB01E63 @default.
- Q92704183 P2860 Q92704183-2254BA46-1194-41A4-9106-DF5B72A217DC @default.
- Q92704183 P2860 Q92704183-2AE9C42C-B97A-44A7-9558-1574F91E358C @default.
- Q92704183 P2860 Q92704183-314869C3-24DC-4295-AAED-B726695069E9 @default.
- Q92704183 P2860 Q92704183-6E03E104-868E-4734-9A54-95B22F0A618E @default.
- Q92704183 P2860 Q92704183-D967E282-8293-41A7-9111-9B6E9DE0F3A7 @default.
- Q92704183 P2860 Q92704183-FC9DF5D4-B218-4898-8413-003F6339466C @default.
- Q92704183 P304 Q92704183-30E1DFB4-0532-4D84-A7BE-13D00912DB25 @default.
- Q92704183 P31 Q92704183-750E9917-8C3D-4552-8E56-FEC4679E8FFF @default.
- Q92704183 P356 Q92704183-CF456629-32D2-4213-B673-EFA8D9CB5865 @default.
- Q92704183 P433 Q92704183-84A3AFC4-01AD-45F8-B30D-F31BFCA81F88 @default.
- Q92704183 P478 Q92704183-FAE2AD98-89C6-4F33-A6D7-862DD333D7BF @default.
- Q92704183 P577 Q92704183-7C7603AB-2D71-4641-8999-89DA810A13D3 @default.
- Q92704183 P698 Q92704183-6C752E19-BBD3-4EAD-AE99-E9BD5C678AF2 @default.
- Q92704183 P356 S2352-3026(19)30025-0 @default.
- Q92704183 P698 30926075 @default.
- Q92704183 P1433 Q26840042 @default.
- Q92704183 P1476 "Effective oral hypomethylating drugs in intermediate-risk or high-risk myelodysplasia: a breakthrough?" @default.
- Q92704183 P2093 "Theo de Witte" @default.
- Q92704183 P2860 Q24563021 @default.
- Q92704183 P2860 Q36910441 @default.
- Q92704183 P2860 Q44646952 @default.
- Q92704183 P2860 Q44826672 @default.
- Q92704183 P2860 Q48693524 @default.
- Q92704183 P2860 Q69984517 @default.
- Q92704183 P2860 Q92704200 @default.
- Q92704183 P304 "e170-e171" @default.
- Q92704183 P31 Q13442814 @default.
- Q92704183 P356 "10.1016/S2352-3026(19)30025-0" @default.
- Q92704183 P433 "4" @default.
- Q92704183 P478 "6" @default.
- Q92704183 P577 "2019-04-01T00:00:00Z" @default.
- Q92704183 P698 "30926075" @default.